Prostate cancer-induced endothelial-to-osteoblast transition generates an immunosuppressive bone tumor microenvironment
This study identifies a prostate cancer-induced endothelial-to-osteoblast transition that creates an immunosuppressive bone tumor microenvironment, reducing the effectiveness of immune checkpoint therapy in bone metastatic castrate-resistant prostate cancer.
bioRxiv · Nov 30, 2023 · PreprintCancer Biology